Details for New Drug Application (NDA): 212516
✉ Email this page to a colleague
The generic ingredient in DRIZALMA SPRINKLE is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the duloxetine hydrochloride profile page.
Summary for 212516
Tradename: | DRIZALMA SPRINKLE |
Applicant: | Sun Pharm |
Ingredient: | duloxetine hydrochloride |
Patents: | 4 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 212516
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Jul 19, 2019 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 13, 2037 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 13, 2037 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 13, 2037 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription